This subject is particularly topical because it is the subject of impending legislation. In 1987 the Government published a White Paper on Human Fertilisation and Embryology", and a Bill based on that White Paper was included in Her Majesty the Queen's speech to Parliament in November 1989.
The pedigree of the White Paper is clear. Patrick Steptoe and Bob Edwards carried out 10 years of patient, dedicated and finally successful research on in vitro fertilization as a treatment for the alleviation of infertility. In 1978 Patrick Steptoe and Bob Edwards begat Louise Brown -with a little help from Mr and Mrs Brown. There are now 3000-4000 babies born as a result of in vitro fertilization in Britain, and probably 20000 in the world as a whole, so it can no longer be regarded as an experimental technique. Louise Brown begat the Warnock Report, with a little help from Dame Mary Warnock, as she then was, and her Committee of Inquiry; and the Warnock Report begat the White Paper. Now this White Paper is very unusual, perhaps unique, in that it contains alternative clauses, on which MPs will have a free vote, with no Government guidance and no intervention from Whips in spite of it being a Government Bill. The alternative clauses (see Table 1 ) concern research -research on human eggs fertilized in vitro, research of the sort that led to the birth of Louise Brown, research that is going on very actively at the present time.
One of the alternative clauses would make it a criminal offence to carry out such research except under licence from a Statutory Licensing Authority. The other alternative clause would make it a criminal Table 1 
. Extract from Department of Health and Social Security Human Fertilisation and Embryology: A Framework for Legislation
The Government therefore proposes that the alternative draft clauses which will be made available to Parliament should be along the following lines:
Prohibiting research It will be a criminal offence to carry out any procedures on a human embryo other than those aimed at preparing the embryo for transfer to the uterus of a woman; or those carried out to ascertain the suitability of that embryo for the intended transfer.
Permitting research
Except as part of a project specifically licensed by the SLA, it will be a criminal offence to carry out any procedures on a human embryo other than those aimed at preparing the embryo for transfer to the uterus of a woman or those carried out to ascertain the suitability of that embryo for the intended transfer. offence to carry out such research under any circumstances. At the end of this paper I shall consider who is likely to vote for this prohibiting clause, and why; but first I want to discuss licensing authorities, and also the nature of the research that would be prohibited.
The Statutory Licensing Authority that would be set up under the Bill would be closely modelled on the recommendations of the Warnock Report". It would oversee the clinical use of human gametes and fertilized eggs, including such techniques of assisted reproduction as in vitro fertilization (IVF) and donor insemination, and it would also oversee all research involving human fertilized eggs. As far as IVF is concerned, the job of overseeing and regulating both clinical practice and research is being done at present by a non-statutory licensing authority, set up in the aftermath of the Warnock Report by the Medical Research Council and the Royal College of Obstetricians and Gynaecologists, when it was clear that the Government had no immediate plans to set up a Statutory Licensing Authority. This Voluntary Licensing Authority (VLA) has recently been recognized by the Government as playing an important and necessary interim role, and its name has therefore been changed to the Interim Licensing Authority, or ILA.
The VLA, or ILA, is constituted as recommended by Warnock, and its guidelines for research closely follow those listed in the Warnock Report. The Warnock Committee had decided that IVF was an acceptable clinical procedure. It therefore judged that the research required to support and improve it should also be permitted, but clearly there must be strict regulation of any such research. For a research proposal to be approved, it must be scientifically sound, it must be on a topic of clinical relevance, and there must have been sufficient work already done on animals to justify moving on to the human. Then there must be informed consent of the donors and approval from the local ethical committee. Fertilized eggs that have been the subject of in vitro research are not to be transferred to the uterus -this is an important caveat -and finally, eggs fertilized in vitro should not be cultured for longer than 14 days. This 14-day limit, which was in the Warnock Report, has often been queried. Is it just arbitrary? Why not 10 days, or 20? Many legal limits are of course arbitrary, in the sense that they do not reflect any pre-existing discontinuity -you have to draw the line somewhere, so you draw it according to various relevant criteria, using a modicum of commonsense to help you along", Much of our law is like that. But the 14-day period is not arbitrary, even in that sense, because it does reflect an underlying biological discontinuity. It also meets the criteria that the Warnock Committee had in mind, namely that it is long enough to allow the research that is required, but ends well before even the beginnings of development of a nervous system.
The biological discontinuity involves the formation of the embryo, as opposed to the conceptus or preembryo that begins at fertilization. The formation of the embryo coincides with the beginning ofindividual development, since twinning can no longer occur, and it also happens to coincide with the completion of implantation, and the time at which the woman would have started her next period.
Implantation starts about a week after fertilization and takes about a week to complete. At the end of those 14 days we have a relatively large mass of tissue derived from the fertilized egg, and all this and the previous stages may be termed the conceptus or preembryo. Almost all this tissue -99% or 99.9% -is extra-embryonic, and the embryo itself forms from a small number of still uncommitted cells, as the socalled primitive streak grows to form the embryonic axis. From now onwards the embryo grows and develops rapidly, so that within a few weeks it has enlarged from a barely visible speck to something a centimetre or two in length, with arms and legs and a nervous system. Figure 1 shows how, in the early stages, all the cells derived from the fertilized egg are uncommitted, all equivalent to one another, but as implantation proceeds more and more become committed to forming the various extra-embryonic structures. The uncommitted cells proliferate, and become smaller and more numerous, but they become a smaller and smaller proportion of the total conceptus. Sometimes too few are left, and no embryo forms; but if all goes well, the primitive streak starts to grow at about 15 days.
Sometimes more than one primitive streak starts to grow -this is the last point at which twinning is possible. So this primitive streak stage marks the beginning of individual-literally, undividabledevelopment, the formation of the individual embryo that will develop into the fetus and then into the baby.
This primitive streak stage represents a real discontinuity in development, and one that is rather easy to recognize.
The ILA has licensed 38 IVF centres in Britain so far, of which 17 are carrying out approved research projects. It publishes an annual report each year -the Fourth Annual Report appeared in 1989and each report contains not only the updated guidelines and a list oflicensed centres and who runs them, but also a list of all approved research projects, and the publications arising from them. The annual reports are useful, because they allow everyone to see just what is being done, by whom, and where.
So what is being done? Most of the research proposals are concerned with improving the success rate of IVF, and devising new approaches for the alleviation of infertility and early embryo loss. About 15% of all couples in this country have an infertility problem. Some are content to remain childless, but for others the desire to have a family is agonizingly strong. Then for tens of thousands of women every year, when they do get pregnant, the fertilized egg never develops properly, and the pregnancy is lost early. Then there is the regulation of fertility, the development of new contraceptive approaches. Hormonal methods are widely used today to suppress the production of eggs, and perhaps in the future similar methods may be devised to suppress the production of sperm also -the so-called 'male contraceptive pill'. But hormonal methods, although effective, have many unwanted side effects. A method that just blocked fertilization would be much better, and much safer. Such a method can only be worked out on eggs that are being fertilized in vitro, as part of a research project. Then there is the very early diagnosis of genetic disease. For couples who are at high risk of producing a baby with one of the many severe and crippling genetic diseases, often lethal in the first few years of life, the aim would be not only to avoid the birth of such babies, but also to avoid the induced abortion of affected fetuses that usually follows an adverse diagnosis by amniocentesis or chorionic villus sampling. I shall mention just one or two of the 50 or so research projects that the VLA has approved up to March 1989 4 • Studies on the process of fertilization itself have to be done on eggs donated by women who are having some surgical intervention such as tubal ligation, and who agree to donate a few eggs for research. These eggs are fertilized in the course of the research project, and are often allowed to divide two or three times, to check whether or not development is normal. Studies are in progress on anti-zona antibodies, aimed at developing a contraceptive vaccines. The zona pellucida is the thin membrane that surrounds the egg, and a coating of antibodies could prevent the sperm from fertilizing the egg. On the other hand if a sperm does occasionally get through the barrier and fertilizes the egg, one needs to be sure that subsequent development of that embryo would not be abnormal.
Recent studies on the effects of temperature on fertilization are interesting, because they have uncovered an important difference between human and mouse. Obviously most of the basic studies on in vitro fertilization, and on culture and transfer of fertilized eggs, have been done on animal models. The mouse is an extremely convenient and valuable model, and one on which I have worked all my life. But it cannot be emphasized too strongly that all species differ from one another, and our own species is no exception; so that the final stages of the work, before any new procedure is applied clinically, must always involve some human as well as animal studies.
In the unfertilized egg, the chromosomes are held in position on fibres. When the egg is cooled to room temperature, these spindle fibres disintegrate, depolymerize. In the mouse, this process is reversible, so that the scattered chromosomes neatly reform on their spindle when the egg is warmed up again", But the human egg seems much more sensitive: after 10-30 minutes at room temperature, 50-100% of spindles did not re-form normally when the eggs were warmed? This means that the chromosomes are likely to scatter after fertilization, so that even if implantation takes place, the resulting embryo will almost certainly die. The increasing realization that keeping the eggs at body temperature is important has contributed to the improved pregnancy rate of IVF over the last few years.
Unlike studies on fertilization, studies on cleavage stages are mostly done on pre-embryos that were fertilized as part of a therapeutic IVF procedure, but which are in excess of the number that can safely be replaced in the uterus. These so-called 'spare' preembryos may then be donated by the couple for research. Much of this research is concerned with the nutritional requirements of the fertilized egg in culture -how to optimize the culture medium, whether special growth factors need to be present -and with the changing metabolism of the embryo as it develops's", what it takes in from the surroundings, and what it excretes. This may give some criterion for diagnosing which two or three of half-a-dozen normal-looking pre-embryos are actually the most healthy, and the most likely to implant and develop if replaced in the uterus. At present no such criterion exists, and the clinician has to guess.
Then there is the possibility mentioned earlier, of diagnosing genetic defects before implantation'P, The concern here is with single gene defects, whether dominant or recessive or sex-linked, defects that cause inherited diseases such as cystic fibrosis, thalassaemia, haemophilia, Duchenne muscular dystrophy, rather than with congenital malformations such as neural tube defects, or with multifactorial conditions. Babies suffering from single gene defects make up about 1% of all births. Of course other methods of prenatal diagnosis, such as amniocentesis and chorionic villus sampling, have allowed many 'high risk' couples to have normal, healthy children; but some couples are unlucky and have several successive pregnancies terminated because the fetus turns out to be affected. At some stage they decide that they cannot face the prospect of another possible abortion, and they stop trying. Preimplantation diagnosis would aim to remove the need for abortion on genetic grounds, and to allow couples to start their pregnancies knowing that the embryo was not affected by the condition that they were carrying.
The approach that is being explored at present involves biopsy of one or more cells during the preimplantation period. One cell could be removed at the 8-cell stage, when all the cells are equivalent and uncommitted, or half a dozen cells could be removed from the placental region at the 100-cell blastocyst stage. The diagnosis would be made on the biopsy sample, and only those pre-embryos shown to be unaffected would be replaced in the woman's uterus. For the 8-cell approach, in vitro fertilization would be needed, but blastocysts could perhaps be recovered by uterine lavage, after normal intercourse and in vivo fertilization.
Of course the amount of tissue removed is minute, so unless the cells in the biopsy can be induced to divide, very special diagnostic methods will have to be used. Some methods can only be used for genes that are expressed.
Certain genes are only expressed in certain cell types -for example genes for making haemoglobin only function in blood cells. But other gene products are needed in every cell, even at the very earliest stages of development, so in principle one can look for either the protein gene product or the messenger RNA. If the cells cannot be persuaded to divide, there are ultra-sensitive enzyme assay methods that can test for an enzyme deficiency in a single cell, and similarly sensitive methods for RNA.
But this raises another problem, which would never have been uncovered without IVF research, and which again emphasizes the risks of extrapolating from mouse to human. It concerns the time in development at which the new embryonic genes start to switch on. In the mouse, the pattern of protein synthesis seen in the unfertilized egg stays more or less the same until the 2·cell stage, and then it changes. The first pattern reflects the pattern of the mother's gene products, passed on in the egg, and it is only at the 2-cell stage that the new embryonic genes take over!', In the human, on the other hand, it is not until the 4-8-cell stage that the embryonic genes start to be expressed". This means that any attempt to do preimplantation diagnosis at the 8·cell stage in the human by looking at gene products would be in danger of diagnosing the mother's genes instead of those of the conceptus.
However, for all genes, whether they are expressed or not, we could detect the gene defect if we could look at the DNA itself. Fortunately, in the last few years a totally new and very powerful method has been invented, called the polymerase chain reaction (PCR), for amplifying a particular stretch of DNA a million times or morel '. Provided at least some of the DNA sequence around the defective region is known, one can take the DNA of a single cell, for example the biopsy specimen from the 8-cell stage, and amplify it to a level where regular DNA diagnostic procedures such as Southern blotting can be used.
So how far has research on pre implantation diagnosis for genetic diseases got? In the mouse, several enzymes have been successfully assayed on single cells taken from an 8-cell stage, or on small groups of cells removed at the blastocyst stage. A deficiency in the sex-linked HPRT gene -which is a model for the human Lesch-Nyhan disease -has been diagnosed correctly, using either 8-cell or blastocyst stages 14 ,15. The biopsied conceptuses were replaced in the uterus where they developed successfully, so that the diagnosis could be validated -and in every case it proved correct.
Using the PCR technique on preimplantation biopsy samples, DNA defects have been successfully detected in a mouse model for human l3-thalassaemia 16 • PCR systems suitable for preimplantation diagnosis are also being worked out for o-thalassaemia and osteogenesis imperfecta in the mouse (M Dziadek, M Bakker and J Proudfoot, personal communication).
In the human, the work has obviously not yet progressed so far, but projects on pre implantation diagnosis of several genetic diseases are under way, including Duchenne muscular dystrophy, cystic fibrosis!" and l3-thalassaemia. These approaches are likely to become a clinical reality within the next 3-4 years if research is allowed to continue. The first diagnosis to be achieved, because it is the easiest, will probably be gender, ie sexing. This is eagerly awaited by women who are carriers of sex-linked gene defects that affect boys only, like Duchenne muscular dystrophy, Lesch-Nyhan disease, and haemophilia18.
At this point some people may wonder why anyone would vote to ban research that is clearly dedicated to promoting human welfare. I think there are three groups of people who would vote for option 1 in the White Paper. Some people are just misinformed. They think that what is involved is a fully formed fetus with arms and legs and a brain. It is not. Even some MPs are not fully informed about the issues at stake, and this is partly the fault of the scientists themselves, who have not taken the trouble to explain what they are doing and why.
Then there are the fundamentalists. The fundamentalist or absolutist position holds that as soon as a human egg is fertilized, it becomes a human person and must not be used for research. This is the view of some religious groups. I have total respect for sincerely held ethical beliefs, but in a multicultural society like ours, I personally doubt whether legislation should be used to impose the beliefs of a few on issues affecting the welfare of many.
Often those opposing IVF research on fundamentalist grounds are prepared to accept the use of IVF as a treatment for infertility. This seems inconsistent, a point that was underlined by the Archbishop of York's forthright remarks'? in the House of Lords debate on the White Paper. He said: 'I believe that research must continue if in vitro fertilization is to continue. One cannot separate them, and I regard as totally unrealistic and indeed immoral any proposal to continue in vitro fertilization without a proper backing in research. This is for the simple and basic reason that imperfect techniques without a backing in research are bad practice medically and, I believe, wrong morally'.
There are other inconsistencies. Even the most devout Catholics have never suggested baptizing fertilized eggs or giving them a Christian burial. It used to be 'At 18 a boy is old enough to die for his country but not old enough to vote'. Now it is 'At 18 hours a conceptus is old enough not to be used for research but not old enough to be baptized'.
Finally, perhaps the largest group of objections are those based on 'thin end ofthe wedge' type arguments. Improving the success rate of IVF is all very well, people say, or even preimplantation diagnosis to avoid having to abort defective fetuses -but is it not all going to lead to genetic manipulation of fertilized eggs, or to production of identical individuals by cloning, or to human-animal hybrids? In fact research on any of those three areas is specifically prohibited by the Licensing Authority, and would be made a criminal offence by the Bill, whether or not licensed research was permitted to continue.
But in any case, the entire social fabric of every society, every community, is built up out of the thin ends of countless wedges. Thin ends of wedges, and how to prevent them becoming thick, is the very essence of social life. We have well-tried and longestablished methods of dealing with them, by introducing systems of regulation, drawing lines, sometimes arbitrary and sometimes based on real distinctions -and then introducing systems of surveillance to see that the lines are not overstepped. We do not forbid people to have fires in their houses just because the city might burn down -but we do have fire regulations, and laws against arson, and we do have fire engines.
For biomedical issues just as for other social issues, I regard 'thin end of the wedge' arguments as being good arguments for regulation and surveillance, but I cannot accept them as arguments for total prohibition.
What would be the likely consequences if the Bill were passed with the inclusion of Clause 1 rather than Clause 2?
On IVF itself, I think the success rate would continue to improve, but more slowly than if research were permitted. Perhaps more important, insights into the causes of infertility and early embryo loss would be missed.
Preimplantation diagnosis of genetic diseases would eventually be developed in other countries. Whether it would then be considered ethical to use it clinically in this country, even though the research required to develop it was prohibited, is a question that would need to be decided.
